Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1053)
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,900
Price
$1.05
Total Value
$2.00K
Shares Held After
383,885
% of Holdings
0.5%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
5,318
Price
$2.10
Total Value
$11.17K
Shares Held After
2,855,318
% of Holdings
0.2%
Inhibrx Biosciences, Inc. (INBX)
Kayyem Jon Faiz — Director
Shares
5,000
Price
$100.00
Total Value
$500.00K
Shares Held After
434,360
% of Holdings
1.2%
Quantum-Si Inc (QSI)
LaPointe Christian — GC&Corp. Secretary
Shares
4,721
Price
$0.76
Total Value
$3.59K
Shares Held After
1,167,913
% of Holdings
0.4%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
2,493
Price
$0.76
Total Value
$1.90K
Shares Held After
1,716,684
% of Holdings
0.1%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
9,709
Price
$0.76
Total Value
$7.39K
Shares Held After
3,639,950
% of Holdings
0.3%
Caris Life Sciences, Inc. (CAI)
Denton John Russel — Senior Vice President, General Counsel, and Secretary
Shares
7,500
Price
$31.82
Total Value
$238.63K
Shares Held After
174,855
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$499.07
Total Value
$79.85K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,358
Price
$497.73
Total Value
$675.91K
Shares Held After
324,603
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,484
Price
$496.83
Total Value
$737.29K
Shares Held After
325,961
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,488
Price
$495.77
Total Value
$737.70K
Shares Held After
327,445
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,337
Price
$494.66
Total Value
$661.36K
Shares Held After
328,933
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,645
Price
$493.70
Total Value
$812.14K
Shares Held After
330,270
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
628
Price
$492.67
Total Value
$309.40K
Shares Held After
331,915
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
736
Price
$491.45
Total Value
$361.70K
Shares Held After
332,543
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
424
Price
$490.54
Total Value
$207.99K
Shares Held After
333,279
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$489.61
Total Value
$117.51K
Shares Held After
333,703
% of Holdings
0.1%
Phio Pharmaceuticals Corp. (PHIO)
Bitterman Robert J — Director
Shares
2,000
Price
$1.03
Total Value
$2.06K
Shares Held After
364,871
% of Holdings
0.5%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research&Development
Shares
3,500
Price
$68.29
Total Value
$239.02K
Shares Held After
153,902
% of Holdings
2.2%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
46,000
Price
$100.72
Total Value
$4.63M
Shares Held After
410,209
% of Holdings
10.1%
Verastem, Inc. (VSTM)
Calkins Daniel — Chief Financial Officer
Shares
55
Price
$7.70
Total Value
$423.50
Shares Held After
118,014
% of Holdings
0.0%
Quantum-Si Inc (QSI)
LaPointe Christian — GC&Corp. Secretary
Shares
9,795
Price
$0.76
Total Value
$7.40K
Shares Held After
1,172,634
% of Holdings
0.8%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
5,172
Price
$0.76
Total Value
$3.91K
Shares Held After
1,719,177
% of Holdings
0.3%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
20,143
Price
$0.76
Total Value
$15.22K
Shares Held After
3,649,659
% of Holdings
0.5%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
9,771
Price
$2.10
Total Value
$20.52K
Shares Held After
2,850,000
% of Holdings
0.3%
OnKure Therapeutics, Inc. (OKUR)
Leverone Jason A. — Chief Financial Officer
Shares
302
Price
$2.97
Total Value
$898.21
Shares Held After
18,500
% of Holdings
1.6%
Legend Biotech Corp (LEGN)
Santos Carlos E — Chief Financial Officer
Shares
5,430
Price
$9.14
Total Value
$49.63K
Shares Held After
14,246
% of Holdings
27.6%
OnKure Therapeutics, Inc. (OKUR)
Saccomano Nicholas A — Director
Shares
87
Price
$2.97
Total Value
$258.76
Shares Held After
11,160
% of Holdings
0.8%
Pharvaris N.V. (PHVS)
Nassif David W. — CFO / CLO
Shares
6,000
Price
$36.47
Total Value
$218.80K
Shares Held After
114,300
% of Holdings
5.0%
Mineralys Therapeutics, Inc. (MLYS)
Warren Eric — Chief Commercial Officer
Shares
7,438
Price
$28.12
Total Value
$209.14K
Shares Held After
38,400
% of Holdings
16.2%
VERACYTE, INC. (VCYT)
Leite John — Global Chief Commercial Off
Shares
4,015
Price
$40.00
Total Value
$160.60K
Shares Held After
124,329
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
843
Price
$496.62
Total Value
$418.65K
Shares Held After
324,443
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,287
Price
$495.71
Total Value
$1.13M
Shares Held After
325,286
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,170
Price
$494.82
Total Value
$1.07M
Shares Held After
327,573
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,680
Price
$493.60
Total Value
$1.32M
Shares Held After
329,743
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,520
Price
$492.97
Total Value
$749.32K
Shares Held After
332,423
% of Holdings
0.5%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
33,000
Price
$97.81
Total Value
$3.23M
Shares Held After
456,209
% of Holdings
6.7%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
533
Price
$95.75
Total Value
$51.03K
Shares Held After
14,219
% of Holdings
3.6%
CYBIN INC. (CYBN)
Halstead Michael — Chief Executive Officer
Shares
100,000
Price
$13.47
Total Value
$1.35M
Shares Held After
168,568
% of Holdings
59.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
2,667
Price
$95.31
Total Value
$254.20K
Shares Held After
29,995
% of Holdings
8.2%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
601
Price
$94.44
Total Value
$56.76K
Shares Held After
32,662
% of Holdings
1.8%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
3,832
Price
$93.32
Total Value
$357.59K
Shares Held After
33,263
% of Holdings
10.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
2,900
Price
$92.37
Total Value
$267.87K
Shares Held After
37,095
% of Holdings
7.3%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
1,764
Price
$196.94
Total Value
$347.40K
Shares Held After
40,352
% of Holdings
4.2%
Bolt Biotherapeutics, Inc. (BOLT)
Quinn William P. — Director
Shares
9,132
Price
$3.24
Total Value
$29.55K
Shares Held After
25,384
% of Holdings
26.5%
Bolt Biotherapeutics, Inc. (BOLT)
Nemec Sarah — Senior VP, Finance and PAO
Shares
4,077
Price
$3.24
Total Value
$13.19K
Shares Held After
17,082
% of Holdings
19.3%
Bolt Biotherapeutics, Inc. (BOLT)
Yonehiro Grant — Chief Operating Officer
Shares
6,850
Price
$3.24
Total Value
$22.17K
Shares Held After
17,269
% of Holdings
28.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$498.25
Total Value
$79.72K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
277
Price
$496.64
Total Value
$137.57K
Shares Held After
324,603
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,330
Price
$495.66
Total Value
$1.15M
Shares Held After
324,880
% of Holdings
0.7%
Showing 1–50 of 1053 transactions (page 1 of 22)